Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Francisco Javier Capote Huelva"'
Use of mogamulizumab for refractory Sézary syndrome in real clinical practice: report of three cases
Autor:
Mercedes Morillo Andújar, Fátima de la Cruz Vicente, Francisco Javier Capote Huelva, Alejandro Ortiz Prieto, David Jiménez Gallo, Mario Linares Barrios, Irene Navarro Navarro, Julián Conejo-Mir Sánchez
Publikováno v:
European Journal of Cancer. 156:S46-S47
Sezary syndrome (SS) is a cutaneous T cell lymphoma (CTLC) with poor prognosis which can present de novo or secondary to mycosis fungoides (MF). We report our experience treating patients with SS with mogamulizumab (n=3). Case 1: A 76-year-old woman
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33fa2d989e138237075707f1395e5338
https://doi.org/10.1016/s0959-8049(21)00713-9
https://doi.org/10.1016/s0959-8049(21)00713-9
Autor:
Eduardo Ríos Herranz, Antonio Alcalá Muñoz, Gemma Ramirez, Antonio Fernández Jurado, José Joaquín Ruíz Arredondo, Francisco Javier Capote Huelva, José Luís Guzmán Zamudio, Miguel Ángel Álvarez Rivas, Alicia Bailén Garcia
Publikováno v:
Hematology and Leukemia. 6:4
Background: The most common therapy in young multiple myeloma patients include induction, mobilization, collection and graft of peripheral blood stem cells. The present phase 2, multi-center, randomized study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58451ce45a4221216ddc8689b023116b
https://doi.org/10.7243/2052-434x-6-4
https://doi.org/10.7243/2052-434x-6-4
Autor:
José Luis Gil García, Carlos Álvarez Rojas, Francisco Javier Capote Huelva, Enrique Calderón Sandubete
Publikováno v:
Medicina Clínica. 117:678-679
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d3bd76d62762e0461e24075e0010bbc
https://doi.org/10.1016/s0025-7753(01)72217-8
https://doi.org/10.1016/s0025-7753(01)72217-8
Autor:
Antonia García-Nieto, José Luis Gil García, Francisco Javier Capote Huelva, María del Carmen Fernández Valle
Publikováno v:
Medicina Clínica. 123:676-676
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::890e7209542a6fd7382eb29ef53be2a4
https://doi.org/10.1157/13068695
https://doi.org/10.1157/13068695
Publikováno v:
Medicina Clínica. 121:757
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::710662adf6c208a4c74f51cfe2798b2e
https://doi.org/10.1016/s0025-7753(03)74085-8
https://doi.org/10.1016/s0025-7753(03)74085-8
Autor:
Pilar Giraldo Castellano, María José Terol Castera, María José Sánchez, Jose Antonio Marquez Navarro, Antonio Salar Silvestre, Carlos Montalbán Sanz, María Dolores Caballero Barrigón, Antonio Gutiérrez García, Juan-Manuel Sancho Cia, Blanca Gonzalez, Miguel Ángel Canales Albendea, Francisco Javier Capote Huelva, Soledad Durán Nieto, Francisco Javier Peñalver Párraga
Publikováno v:
Web of Science
Objectives: To evaluate the efficacy and toxicity of a response-adapted therapy with rituximab/bendamustine/mitoxantrone/dexamethasone (RBMD), followed by rituximab (R) maintenance therapy in patients with relapsed or refractory follicular lymphoma (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::092287eb29227e62c22a0a6f30a70cd2
https://publons.com/wos-op/publon/53891760/
https://publons.com/wos-op/publon/53891760/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.